A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that ...

The role of surgery for malignant pleural mesothelioma encompasses the need for rapid diagnosis, preoperative staging and surgical resection, and also the need for a greater biological understanding ...

Surgery for malignant pleural mesothelioma after radiotherapy may increase overall survival rates, according to a study. However, study authors note that the procedure should only be adopted in ...

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer ...

Please provide your email address to receive an email when new articles are posted on . Previous studies investigated whether surgery may extend survival among patients with malignant pleural ...

Patients with malignant pleural mesothelioma (MPM) lived 6 months longer, on average, when they had surgery in addition to chemotherapy, a large retrospective analysis showed. The addition of surgery ...

Chemical pleurodesis. The surgeon puts a chemical, usually talc, into the pleural space (the space between your lungs and your chest wall.)‌ Mechanical pleurodesis. The surgeon abrades (brushes) the ...

"Pleural effusion is a common complication after bypass surgery", say researchers who recently carried out a study of 400 patients who had undergone bypass heart surgery. Pleural effusion involves the ...

A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low ...

Surgical treatment improved outcomes of patients with malignant pleural mesothelioma, according to a SEER database analysis. Researchers even observed the benefit among elderly individuals. More than ...

The median survival of patients undergoing trimodality therapy is 1–2 years, but some patients (19%) can live for 3–14 years. To improve outcomes and survival, the focus of clinical research over the ...